We are live on ! Find out more
GSK icon

GSK
GSK

1,031 hedge funds and large institutions have $20.7B invested in GSK in 2026 Q1 according to their latest regulatory filings, with 141 funds opening new positions, 315 increasing their positions, 381 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 82

63% more call options, than puts

Call options by funds: $222M | Put options by funds: $137M

36% more funds holding in top 10

Funds holding in top 10: 11 → 15 (+4)

5% more capital invested

Capital invested by funds: $19.6B → $20.7B (+$1.03B)

4% more funds holding

Funds holding: 995 → 1,031 (+36)

1.11% less ownership

Funds ownership: 19.53% → 18.42% (-1.1%)

17% less repeat investments, than reductions

Existing positions increased: 315 | Existing positions reduced: 381

Holders
1,031
Holders Change
+36
Holders Change %
+3.62%
% of All Funds
12.69%
Holding in Top 10
15
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+36.36%
% of All Funds
0.18%
New
141
Increased
315
Reduced
381
Closed
82
Calls
$222M
Puts
$137M
Net Calls
+$85.7M
Net Calls Change
-$49.4M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$282M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$154M
3
Goldman Sachs
Goldman Sachs
New York
+$127M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$111M
5
BlackRock
BlackRock
New York
+$94.1M

Top Sellers

1
Dodge & Cox
Dodge & Cox
California
-$534M
2
JEST
JTC Employer Solutions Trustee
Jersey
-$292M
3
UBS Group
UBS Group
Switzerland
-$227M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$145M
5
Holocene Advisors
Holocene Advisors
New York
-$141M
Name Holding Trade Value Shares
Change 		Change in
Stake
FIA
1101
FNY Investment Advisers
New York
– -$4K -100 Closed
PP
1102
Pingora Partners
Wyoming
– -$4.9K -100 Closed
SHF
1103
Safe Harbor Fiduciary
Florida
– -$4.9K -100 Closed
BFG
1104
Brandywine Financial Group
Tennessee
– -$3.92K -80 Closed
NL
1105
Navalign LLC
California
– -$3.92K -80 Closed
NEWAS
1106
N.E.W. Advisory Services
Wisconsin
– -$3.04K -62 Closed
WPA
1107
Wealth Preservation Advisors
Tennessee
– -$2.99K -61 Closed
DF
1108
DecisionPoint Financial
Arizona
– -$2.8K -57 Closed
CRI
1109
Commonwealth Retirement Investments
Virginia
– -$2.75K -56 Closed
MW
1110
Merited Wealth
Florida
– -$2.55K -52 Closed
WFA
1111
West Financial Advisors
Iowa
– -$1.72K -35 Closed
WW
1112
Winnow Wealth
Texas
– -$1.75K -35 Closed
ANBT
1113
American National Bank & Trust
Texas
– -$1.42K -29 Closed
CCMI
1114
Creative Capital Management Investments
California
– -$981 -20 Closed
41 42 43 44
45

GSK Hedge Fund Activity: Q1 2026 in Review

1,031 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q1 2026, worth a combined $20.7B — up 5.2% from $19.6B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new GSK positions and 82 closed out — a net gain of 59 holders — while 315 added to existing stakes and 381 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $282M. The largest seller was Dodge & Cox, cutting an estimated $534M.

  • 1,031 institutional investors held GSK (GSK) as of Q1 2026, up from 995 in Q4 2025.
  • Funds reported $20.7B of GSK stock for Q1 2026, up 5.2% quarter-over-quarter.
  • 141 funds opened new GSK positions in Q1 2026 and 82 closed out, a net change of +59 holders.
  • The largest GSK buyer in Q1 2026 was Morgan Stanley, an estimated $282M added.
  • The largest GSK seller in Q1 2026 was Dodge & Cox, an estimated $534M sold.

Based on aggregated 13F filings for Q1 2026.